TET2 and essential thrombocythemia: The mutations are more prevalent in later stages of MPNs and similar to mutations in TET2 the acquisition order of the mutation relative to JAK2V617F appears to influence the phenotype such that patients with initial JAK2V617F mutation have a tendency to present with PV or MF rather than ET [54].